Access Oncology & Specialty Medicines
in Vietnam

Access to oncology medicines Vietnam patients require continues to present real clinical challenges. Many of the most effective cancer treatment drugs Vietnam oncologists now recommend — including newer targeted therapies, immunotherapy agents, and combination regimens — are either not yet registered with the Drug Administration of Vietnam or are available only in limited quantities through public hospital procurement channels.

Medsmonk supports patients seeking access to a broad range of cancer treatment drugs Vietnam specialists prescribe, including medicines where local supply is inconsistent or where DAV registration is pending. All oncology medicine orders require a valid prescription from a licensed physician in Vietnam. Authenticity documentation and quality certificates accompany every supply.

Targeted Therapy Drugs Vietnam

Targeted therapy drugs Vietnam patients may need include EGFR inhibitors, ALK inhibitors, KRAS and BRAF-targeted agents, CDK4/6 inhibitors, PARP inhibitors, and HER2-directed therapies. These precision medicines are central to modern oncology protocols for lung, breast, colorectal, and other solid tumour types. Where these medicines are unavailable or in limited supply locally, international sourcing may provide a compliant access pathway with a valid prescription.

Lung Cancer Treatment Drugs Vietnam

Among the most frequently requested medicines are lung cancer treatment drugs Vietnam specialists prescribe, including osimertinib (third-generation EGFR inhibitor), lorlatinib (third-generation ALK inhibitor), alectinib, and combination platinum-based regimens. These treatments represent the current standard of care for advanced non-small cell lung cancer (NSCLC) and are among the oncology medicines most commonly sought through international sourcing by patients in Vietnam.

Chemotherapy & Immunotherapy

In addition to targeted agents, Medsmonk supports access to conventional chemotherapy medicines and immunotherapy agents — including PD-1 and PD-L1 checkpoint inhibitors — where local hospital supply or formulary availability presents barriers for patients in Ho Chi Minh City, Hanoi, and across Vietnam.

Medsmonk supports access to HIV medicines Vietnam patients require — including antiretroviral therapy (ART) regimens and pre-exposure prophylaxis (PrEP) — through compliant international sourcing. While Vietnam's national ART programme covers a significant portion of people living with HIV, access to specific newer ART regimens, second- and third-line treatment options, or PrEP medicines can be inconsistent or limited through standard local channels.

All HIV medicine orders require a valid prescription from a licensed physician. Every HIV medicine shipment is handled with complete professional confidentiality. Outer packaging is fully discreet with no identifying medical content visible on the exterior — a standard we apply consistently to all sensitive medicine categories.

Vietnam carries one of the highest burdens of chronic Hepatitis B in Southeast Asia, and Hepatitis C infection also remains a significant public health concern. For many patients, access to the most effective hepatitis treatment Vietnam physicians prescribe — including newer direct-acting antivirals (DAAs) for Hepatitis C and tenofovir alafenamide (TAF) for Hepatitis B — may be limited through the public health system or present consistency challenges through private supply channels.

Medsmonk supports access to Hepatitis B antiviral medicines including entecavir and tenofovir alafenamide, and pan-genotypic Hepatitis C DAA regimens including sofosbuvir/velpatasvir and glecaprevir/pibrentasvir combinations. All hepatitis treatment orders require a valid prescription from a licensed physician in Vietnam. Quality and authenticity documentation accompanies every supply.